Twin Focus Capital Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Twin Focus Capital Partners's PFE Position: Q3 2023 in Review
Twin Focus Capital Partners sold out of Pfizer (PFE) in Q3 2023, closing a stake of 11,323 shares — an estimated $415K sold.
Twin Focus Capital Partners first reported a position in PFE in Q2 2014 and held it in 18 quarters. The position peaked at $624K in Q4 2021. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.
- Twin Focus Capital Partners reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
- Twin Focus Capital Partners sold 11,323 Pfizer shares in Q3 2023, an estimated $415K.
- Twin Focus Capital Partners first reported a position in Pfizer in Q2 2014 and held it in 18 quarters.
- Twin Focus Capital Partners's Pfizer position peaked at $624K in Q4 2021.
- 2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.
Based on Twin Focus Capital Partners's 13F filing for Q3 2023, filed 13 Nov 2023.